Analytical Data
-
基因名
PHLPI
- 应用
-
别名
Allergen Phl p I Allergen: Phl p 1
-
种属
Phleum pratense
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P43213
-
表达区间
24-263aa
-
分子量
42.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PHLPI (Phospholipid-Protein Interactions) is a significant area of research given its critical role in various biological processes, including cell signaling, membrane dynamics, and protein function. Research on PHLPI recombinant proteins has gained momentum due to their potential applications in drug development, synthetic biology, and understanding disease mechanisms. As cells utilize phospholipids to create membranes and facilitate protein interactions, studying these recombinant proteins can elucidate how proteins associate with lipid membranes, influencing cellular function. Furthermore, such studies contribute to the design of biomimetic systems and lipid-based drug delivery methods, enhancing therapeutic efficacy and specificity. The enhanced understanding of PHLPI through recombinant proteins also provides insights into various pathologies, including cancer and neurodegenerative diseases, where membrane protein interactions are disrupted. Consequently, this research not only advances our fundamental understanding of cellular biology but also opens pathways for innovative therapeutic strategies.
